Osteopontin-CD44 signaling in the glioma perivascular niche enhances cancer stem cell phenotypes and promotes aggressive tumor growth.
about
Pancreatic cancer stem cell markers and exosomes - the incentive pushCancer stem cells (CSCs), cervical CSCs and targeted therapiesGlioma Stem Cells and Their Microenvironments: Providers of Challenging Therapeutic TargetsTherapeutic strategies targeting cancer stem cellsRemodelling the extracellular matrix in development and diseaseConcise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic TargetCD44, Hyaluronan, the Hematopoietic Stem Cell, and Leukemia-Initiating CellsOvercoming therapeutic resistance in glioblastoma: the way forwardCD44-mediated adhesion to hyaluronic acid contributes to mechanosensing and invasive motilityIntercellular communication in malignant pleural mesothelioma: properties of tunneling nanotubes.Chitosan promotes cancer progression and stem cell properties in association with Wnt signaling in colon and hepatocellular carcinoma cells.Soluble bone-derived osteopontin promotes migration and stem-like behavior of breast cancer cellsCcl5 establishes an autocrine high-grade glioma growth regulatory circuit critical for mesenchymal glioblastoma survival.Contribution of the Microenvironmental Niche to Glioblastoma Heterogeneity.Biphasic Dependence of Glioma Survival and Cell Migration on CD44 Expression LevelMRI-localized biopsies reveal subtype-specific differences in molecular and cellular composition at the margins of glioblastoma.A Cell-Surface Membrane Protein Signature for Glioblastoma.Glioma-associated microglia/macrophages display an expression profile different from M1 and M2 polarization and highly express Gpnmb and Spp1.Concise review: bullseye: targeting cancer stem cells to improve the treatment of gliomas by repurposing disulfiram.Targeting miR-381-NEFL axis sensitizes glioblastoma cells to temozolomide by regulating stemness factors and multidrug resistance factorsOsteopontin promotes a cancer stem cell-like phenotype in hepatocellular carcinoma cells via an integrin-NF-κB-HIF-1α pathwayInside-out Regulation of Ectodomain Cleavage of Cluster-of-Differentiation-44 (CD44) and of Neuregulin-1 Requires Substrate Dimerization.Histological Characterization of the Tumorigenic "Peri-Necrotic Niche" Harboring Quiescent Stem-Like Tumor Cells in GlioblastomaLoss of CX3CR1 increases accumulation of inflammatory monocytes and promotes gliomagenesis.Nanoparticles for Targeting Intratumoral Hypoxia: Exploiting a Potential Weakness of Glioblastoma.Distinct Intracellular Domain Substrate Modifications Selectively Regulate Ectodomain Cleavage of NRG1 or CD44.Single-cell sequencing maps gene expression to mutational phylogenies in PDGF- and EGF-driven gliomasIdentification of therapeutic targets for glioblastoma by network analysis.Genetically engineered rat gliomas: PDGF-driven tumor initiation and progression in tv-a transgenic rats recreate key features of human brain cancer.The Combined Influence of Hydrogel Stiffness and Matrix-Bound Hyaluronic Acid Content on Glioblastoma Invasion.The transcriptome and miRNome profiling of glioblastoma tissues and peritumoral regions highlights molecular pathways shared by tumors and surrounding areas and reveals differences between short-term and long-term survivors.Reversion to an embryonic alternative splicing program enhances leukemia stem cell self-renewal.The fibroblast Tiam1-osteopontin pathway modulates breast cancer invasion and metastasis.Arsenic trioxide disrupts glioma stem cells via promoting PML degradation to inhibit tumor growthModeling the tumor microenvironment using chitosan-alginate scaffolds to control the stem-like state of glioblastoma cells.Metastasis prevention by targeting the dormant niche.The EGF Receptor Promotes the Malignant Potential of Glioma by Regulating Amino Acid Transport System xc(-)Interleukin-6 enhances cancer stemness and promotes metastasis of hepatocellular carcinoma via up-regulating osteopontin expression.HMGA2 sustains self-renewal and invasiveness of glioma-initiating cells.CD44 expression in endothelial colony-forming cells regulates neurovascular trophic effect.
P2860
Q26741215-DF4C8178-7BA5-4672-9059-9909083C107CQ26747144-8E23748C-874C-43C7-BE04-5772DAB9DABAQ26765758-476B1D90-8C66-409B-9D21-9740FC1C12ECQ26781398-A1FB1CA4-E653-4B75-A466-42C90EA6F5E0Q26864798-B4F10482-95A3-4E44-B8DF-8F2E4DB2A01EQ28083115-D8AE2147-F5AC-4B8E-966A-5AC694CC513DQ28084610-DE2B0FE0-A32C-4C5E-97FE-512300E2B124Q29248396-0A574149-6C5A-455D-A28F-89BBFCB28C8FQ30594175-36C6C2A5-BA1B-4A6F-A4B7-805CAF9FA3C2Q30596678-8DAECFA2-8B92-48FD-AD24-210349CCC3E7Q30843748-8E576C46-6C4F-467F-BFDF-D7862D2FCAC5Q33675150-48406A43-9341-4582-8788-8184766B76F2Q33779328-8C0D45EB-757A-43DE-8206-D8F8BF030E5AQ33786677-B4C4F5A3-4BED-4832-818D-4A1BC990BC9CQ33874532-CA0E9A40-77C8-4115-A675-8BA8AACE34B7Q34119993-E9062501-7FB8-4D32-B6C3-2BA3C582BEFAQ34554512-40E28741-D73A-45BA-97A8-9657A27BD7E7Q35058891-617DD10B-B4A5-40D0-A438-1C51DDF93C00Q35542866-3D5946D5-4FCA-4D95-B98D-203DFA789E13Q35545648-A72B8852-C09E-470C-B0ED-D0B4F433449BQ35740040-A46F9E08-F57D-42CF-B362-3BA0F026D927Q35837076-0F93DBDA-5A8B-43B4-A973-2C9ECDAD2E28Q35901357-DA03457A-F574-4CCE-BA1A-D6884648ED13Q36020925-EBB037E2-CF16-4B98-A423-5E121CD629A4Q36031889-EEF1D64D-AC17-47BF-AA5E-8374DDCE94D8Q36033357-861B68F5-5AD0-431D-AC05-B9DBD1C6F352Q36204396-4EC745D3-CC8C-47BA-BB96-D505866E2261Q36271573-DD0AD258-C870-406B-824D-B3F426B08D1AQ36328555-C3CDD9DB-2AF2-46C3-9D2D-5B213C05F4D7Q36335596-A4999382-1BDD-41F5-BB78-89FB2FF6B81AQ36356011-452A75F0-EFA4-4383-B8FA-A9C4AF08D7A1Q36394240-A18702F2-4410-4FA4-97C9-1AD3ED6BD427Q36513706-94402BE0-A0D5-4B88-BA8C-93B06AEDD756Q36545726-BEFF38FF-0E28-4A19-9EC8-4F38DD25ECA4Q36717318-D250B230-7266-4166-BA05-CE50DE2AE285Q36829245-637474DF-8181-4BF9-A2DC-F8D3520D7712Q36917721-AC486065-2111-41EC-B439-39249E610A09Q37298268-313638F4-1666-481C-8D1C-765AFAE42967Q37536896-1C297A70-2910-4CD7-981A-C5578DBC8800Q37599559-95695F78-A5E6-4643-9211-E297710AE39A
P2860
Osteopontin-CD44 signaling in the glioma perivascular niche enhances cancer stem cell phenotypes and promotes aggressive tumor growth.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Osteopontin-CD44 signaling in ...... motes aggressive tumor growth.
@en
type
label
Osteopontin-CD44 signaling in ...... motes aggressive tumor growth.
@en
prefLabel
Osteopontin-CD44 signaling in ...... motes aggressive tumor growth.
@en
P2093
P2860
P50
P1433
P1476
Osteopontin-CD44 signaling in ...... omotes aggressive tumor growth
@en
P2093
Amanda M Katz
Boyoung Wee
Elin J Ekström
Eric C Holland
Jason T Huse
Jillian L Werbeck
John J Halliday
Nduka M Amankulor
P2860
P304
P356
10.1016/J.STEM.2014.01.005
P407
P577
2014-03-01T00:00:00Z